Pulmonary hypertension in patients with chronic myeloproliferative disorders

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.

Original languageEnglish
Pages (from-to)400-410
Number of pages11
JournalEuropean Respiratory Review
Volume24
Issue number137
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Myeloproliferative Disorders
Pulmonary Hypertension
Chronic Disease
Epidemiology

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pulmonary hypertension in patients with chronic myeloproliferative disorders. / Adir, Yochai; Elia, Davide; Harari, Sergio.

In: European Respiratory Review, Vol. 24, No. 137, 01.09.2015, p. 400-410.

Research output: Contribution to journalArticle

@article{4ec97adf57584fbcaad689edb56fd707,
title = "Pulmonary hypertension in patients with chronic myeloproliferative disorders",
abstract = "Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.",
author = "Yochai Adir and Davide Elia and Sergio Harari",
year = "2015",
month = "9",
day = "1",
doi = "10.1183/16000617.0041-2015",
language = "English",
volume = "24",
pages = "400--410",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "137",

}

TY - JOUR

T1 - Pulmonary hypertension in patients with chronic myeloproliferative disorders

AU - Adir, Yochai

AU - Elia, Davide

AU - Harari, Sergio

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.

AB - Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.

UR - http://www.scopus.com/inward/record.url?scp=84940652737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940652737&partnerID=8YFLogxK

U2 - 10.1183/16000617.0041-2015

DO - 10.1183/16000617.0041-2015

M3 - Article

VL - 24

SP - 400

EP - 410

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 137

ER -